BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6893077)

  • 1. [Graves' disease. Predominance of the DRw3 antigen (author's transl)].
    Allanic H; Fauchet R; Lorcy Y; Heim J; Guéguen M; Leguerrier AM; Genetet B
    Nouv Presse Med; 1980 Jun; 9(26):1823-6. PubMed ID: 6893077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA and Graves' disease: an association with HLA-DRw3.
    Allannic H; Fauchet R; Lorcy Y; Heim J; Gueguen M; Leguerrier AM; Genetet B
    J Clin Endocrinol Metab; 1980 Oct; 51(4):863-7. PubMed ID: 6932402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HLA DRW3 and Graves' disease (author's transl)].
    Allannic H; Fauchet R; Lorcy Y; Heim J; Gueguen M; Leguerrier AM; Genetet B
    Ann Endocrinol (Paris); 1980; 41(1):70-2. PubMed ID: 6893111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of human leukocyte D locus related antigens in Graves' disease.
    Farid NR; Sampson L; Noel EP; Barnard JM; Mandeville R; Larsen B; Marshall WH; Carter ND
    J Clin Invest; 1979 Jan; 63(1):108-13. PubMed ID: 105012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of HLA antigens in the manifestation and course of Graves' disease.
    Stenszky V; Kozma L; Balazś C; Bear JC; Farid NR
    Mol Biol Med; 1986 Feb; 3(1):53-62. PubMed ID: 3485758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity by cluster analysis techniques of Graves' patients typed for HLA DR and IgG heavy chain markers.
    Frecker MF; Preus M; Kozma L; Krasrits E; Stenszky V; Balazś C; Farid NR
    Mol Biol Med; 1986 Feb; 3(1):63-71. PubMed ID: 3083192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Human leukocyte antigen (HLA) complex and anti-thyroidal antibodies in Graves' disease].
    Lacka K; Kordel M; Gembicki M
    Pol Tyg Lek; 1989 Feb 13-20; 44(7-8):179-81. PubMed ID: 2682567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA associations with autoimmune-type chronic active hepatitis: identification of B8-DRw3 haplotype by family studies.
    Mackay IR; Tait BD
    Gastroenterology; 1980 Jul; 79(1):95-8. PubMed ID: 7380229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HLA B8 and Graves' disease (author's transl)].
    Jaffiol C; Seignalet J; Baldet L; Robin M; Lapinski H; Mirouze J
    Ann Endocrinol (Paris); 1976; 37(4):219-26. PubMed ID: 1037358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of HLA antigen BW35 with severe Graves' ophthalmopathy.
    Sergott RC; Felberg NT; Savino PJ; Blizzard JJ; Schatz NJ; Sanford CA
    Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):124-7. PubMed ID: 6600737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DR associations with Graves' disease in eastern Hungary.
    Stenszky V; Kozma L; Balazs C; Farid NR
    Clin Invest Med; 1983; 6(3):181-4. PubMed ID: 6580983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective Fc-receptor functions associated with the HLA-B8/DRw3 haplotype: studies in patients with dermatitis herpetiformis and normal subjects.
    Lawley TJ; Hall RP; Fauci AS; Katz SI; Hamburger MI; Frank MM
    N Engl J Med; 1981 Jan; 304(4):185-92. PubMed ID: 6969363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The possible influence of HLA-A1, B8 antigens on the course of Graves' disease.
    Balázs CS; Stenszky V; Kozma L; Leövey A
    Biomedicine; 1978 Nov; 29(8):263-4. PubMed ID: 581746
    [No Abstract]   [Full Text] [Related]  

  • 14. HLA haplotypes in familial Graves' disease.
    Farid NR; Moens H; Larsen B; Payne R; Saltman K; Fifield F; Ingram DW
    Tissue Antigens; 1980 May; 15(5):492-500. PubMed ID: 6893771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Celiac disease and HLA in a hospital population of Uruguay].
    Maggi R; Jasinski C; Balás R; Martinotti M; Crespo J; Paciel J; Galbarin E
    Arq Gastroenterol; 1982; 19(2):87-90. PubMed ID: 7185359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of HLA types and clinical findings in Japanese patients with hyperthyroid Graves' disease: evidence indicating the existence of four subpopulations.
    Inoue D; Sato K; Enomoto T; Sugawa H; Maeda M; Inoko H; Tsuji K; Mori T; Imura H
    Clin Endocrinol (Oxf); 1992 Jan; 36(1):75-82. PubMed ID: 1559302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human lymphocyte antigens in Graves' disease: correlation with persistent course of disease.
    Baldini M; Pappalettera M; Lecchi L; Orsatti A; Meroni L; Tozzi R; Scalamogna M; Cantalamessa L
    Am J Med Sci; 1995 Jan; 309(1):43-8. PubMed ID: 7825652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-A1, B8, DRw3 in patients with a distinct form of lupus erythematosus.
    Stastny P; Gilliam JN
    Transplant Proc; 1979 Dec; 11(4):1869-70. PubMed ID: 531931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA/Bf haplotypes in a Newfoundland family.
    Larsen B; Pepper B; Barnard JM; Farid NR
    Tissue Antigens; 1978 Jul; 12(1):39-43. PubMed ID: 581240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of HLA antigens in Graves' hyperthyroidism and mitral valve prolapse.
    Kontopoulos A; Harsoulis P; Adam K; Papadopoulos G; Polymenidis Z; Boudoulas H
    J Heart Valve Dis; 1996 Sep; 5(5):543-7. PubMed ID: 8894996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.